Neogen (NEOG) Total Debt (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 0.05% |
| Nov 30, 2025 | 0.05% |
| Aug 31, 2025 | -11.36% |
| May 31, 2025 | 0.39% |
| Feb 28, 2025 | 0.08% |
| Nov 30, 2024 | 0.08% |
| Aug 31, 2024 | -0.19% |
| May 31, 2024 | 0.36% |
| Feb 29, 2024 | 0.08% |
| Nov 30, 2023 | 0.08% |
| Aug 31, 2023 | 0.08% |
| May 31, 2023 | 0.08% |
| Feb 28, 2023 | -4.25% |
| Feb 28, 2017 | 43.36% |
| Nov 30, 2016 | 1.21% |
| Aug 31, 2016 | -8.21% |
| May 31, 2016 | 15.00% |
| Feb 29, 2016 | -3.17% |
| Nov 30, 2015 | 4.31% |
| Aug 31, 2015 | 1.71% |
| May 31, 2015 | -2.33% |
| Feb 28, 2015 | 1.16% |
| Nov 30, 2014 | 2.17% |
| Aug 31, 2014 | 8.14% |
| May 31, 2014 | -16.23% |
| Feb 28, 2014 | 3.65% |
| Nov 30, 2013 | 1.74% |
| Aug 31, 2013 | 1.14% |
| May 31, 2013 | 3.24% |
| Feb 28, 2013 | -30.34% |
| Nov 30, 2012 | 10.84% |
| Aug 31, 2012 | 1.74% |
| May 31, 2012 | -43.38% |
| Feb 29, 2012 | 3.25% |
| Nov 30, 2011 | -0.45% |
| Aug 31, 2011 | -1.85% |